Publication Date:
2013-08-29
Description:
Key Points Rituximab may be a safe and effective therapy in patients with both large granular lymphocyte leukemia and rheumatoid arthritis. LGLL in some patients with rheumatoid arthritis may be a reactive manifestation of chronic autoantigen stimulation rather than a true concomitant malignancy.
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
,
Medicine
Permalink